Everything below concerns lyophilization. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Stability testing examines how the molecule changes under controlled stress. Thermal stress, light exposure, and extremes of pH are applied separately so that each degradation route can be attributed to a specific cause. The main observed changes are oxidation, deamidation, and aggregation into dimers or higher-order species. Accelerated studies at elevated temperature are used to estimate behavior over longer periods, though such extrapolation carries uncertainty. For a lyophilized powder, residual moisture and the choice of bulking agent strongly influence how quickly these changes appear.
Practical handling centers on limiting moisture, oxygen, and temperature excursions. Lyophilized material is generally held at or below minus twenty degrees Celsius, protected from light and kept sealed until use. Once reconstituted, solutions are typically kept cold and used within a short window because hydrolysis and microbial growth both accelerate in liquid form. Repeated freeze-thaw cycles are avoided, since they promote aggregation. Vial contents should be inspected for particulates and clarity before analysis, and working aliquots are prepared to reduce the number of times the stock is opened.
Quantitation of the peptide relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection, typically at 214 nanometers, where the peptide bond absorbs. Identity is confirmed by mass spectrometry, most often electrospray ionization coupled to liquid chromatography, and by peptide mapping after enzymatic digestion. Because related impurities differ only slightly in sequence or modification, method development emphasizes resolution rather than speed. Purity is usually reported as a percentage of the main peak area, with individual impurities listed separately when they exceed a defined reporting threshold.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | GHRH analog family |
| Residue count | 44 amino acids | Matches human GHRH(1-44) backbone |
| N-terminal group | trans-3-hexenoyl | Main structural difference from native hormone |
| Appearance | White to off-white powder | Lyophilized solid form |
| Solubility class | Freely soluble in water | Peptide character; less soluble in organic solvents |
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
Once reconstituted, the peptide is handled as a solution and is less stable than the lyophilized powder. Aqueous solutions are commonly kept cold and used within a defined period. Buffer composition and pH influence degradation rates, with extremes of acidity or alkalinity accelerating hydrolysis. Preservatives may be added in multi-dose formats to limit microbial growth. Freezing and thawing of solutions is generally avoided because it can cause precipitation or loss of activity.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass and detects chemical modifications. Peptide mapping and amino acid analysis can verify sequence integrity. Water content is measured by Karl Fischer titration, and residual solvents may be checked by gas chromatography. These methods together support batch-to-batch consistency and routine quality control.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
== Speech at the Ceremony Marking the 65th Anniversary of the Basic Law, Germany’s Constitution (2014) == On May 23, 2014, the German Parliament Bundestag held a ceremony commemorating the proclamation of the Basic Law on May 23, 1949. Kermani was invited as the keynote speaker. In his speech, he analyzed the language of the Basic Law, comparing its impact to that of the Luther Bible. Kermani discussed the historic progress made in the postwar period and noted that the Basic Law had created a new reality. Kermani praised the Federal Republic of Germany for upholding constitutional norms. He also commended German society for its willingness to bring about integration and its efforts in this regard. He mentioned Willy Brandt several times. Referring to Brandt, Kermani noted, “If I were to name a single day, a single event, a single gesture in postwar German history for which the word ‘dignity’ seems appropriate, (…) it would be Brandt’s kneeling in Warsaw.” Kermani sharply criticized the restriction of the right to asylum through the 1993 amendment to the Basic Law (asylum compromise), which he described as a distortion of Article 16a and a mutilation of the Constitution. Nevertheless, he emphasized the opportunities that the Federal Republic of Germany has offered immigrants. He concluded his speech—on their behalf—with the words Thank you, Germany. Some members of the CDU/CSU parliamentary group criticized the speech as one-sided or biased; Georg Nüßlein (CSU) left the chamber. In the German media, however, the speech was well received and positively discussed.
== Octopole reaction system == Another implementation of this type of interference removal is an octopole (instead of a quadrupole) collision cell, implemented by Agilent's 7500 series. The octopole reaction system (ORS)) uses only helium or hydrogen and the volume of the cell is smaller than that of a DRC. The small molecules of helium and hydrogen collide with the large, unwanted polyatomic ions formed in the plasma and break them up into other ions that can be separated in the quadrupole mass analyser. However, unlike the DRC the OCR system is based only on collision reactions and not on chemical reactions.
=== Italy === Since the Fleischmann and Pons announcement, the Italian national agency for new technologies, energy and sustainable economic development (ENEA) has funded Franco Scaramuzzi's research into whether excess heat can be measured from metals loaded with deuterium gas. Such research is distributed across ENEA departments, CNR laboratories, INFN, universities, and industrial laboratories in Italy, where the group continues to try to achieve reliable reproducibility (i.e. getting the phenomenon to happen in every cell, and inside a certain frame of time). In 2006–2007, the ENEA started a research program which claimed to have found excess power of up to 500 percent, and in 2009, ENEA hosted the 15th cold fusion conference.
=== Dehydrated and freeze-dried === Dehydrated or freeze-dried meals come in raw and cooked forms. Products are usually air-dried or frozen, then dehydrated (freeze-dried) to reduce moisture to the level where bacterial growths are inhibited. The appearance is very similar to dry dog pellets. The typical feeding methods include adding warm water before serving. There is some concern of nutrients, such as vitamins, being lost during the dehydration process. Specialty small batches sold through specialty or online stores generally consist of some form of cooked meat, ground bone, pureed vegetables, taurine supplements, and other multivitamin supplements. Some pet owners use human vitamin supplements, and others use vitamin supplements specifically engineered for dogs.
Sources: en.wikipedia.org
proteolysis The decomposition of proteins into their component polypeptides or individual amino acids by cleaving the peptide bonds linking the amino acids together via hydrolysis. Proteolysis is an important reaction used not only for degrading and inactivating proteins but sometimes also to activate them by removing amino acid residues which inhibit their activity. It is usually catalyzed by enzymes known as proteases.
==== Earthquakes ==== Some monitoring stations have reported that earthquakes are sometimes preceded by a spike in ultra-low-frequency (ULF) activity. A notable example of this occurred before the 1989 Loma Prieta earthquake in California, although a subsequent study indicated that this was little more than a sensor malfunction. On December 9, 2010, geoscientists announced that the DEMETER satellite observed a dramatic increase in ULF radio waves over Haiti in the month before the magnitude 7.0 Mw 2010 earthquake. Researchers are attempting to learn more about this correlation to determine whether this method can be used as part of an earthquake early warning system.
Russia claimed to have taken the village of Shumy, ten kilometers east of Toretsk. Seven people were killed and 36 others were injured in a Russian attack in Vilniansk, Zaporizhzhia Oblast. Three people were killed in separate attacks in Donetsk and Kherson Oblasts. Russian officials claimed that five people, including two children, were killed in a Ukrainian drone strike in Gorodishche, Kursk Oblast.
== Unrelated words in -omics == The word "comic" does not use the "omics" suffix; it derives from Greek "κωμ(ο)-" (merriment) + "-ικ(ο)-" (an adjectival suffix), rather than presenting a truncation of "σωμ(ατ)-". Similarly, the word "economy" is assembled from Greek "οικ(ο)-" (household) + "νομ(ο)-" (law or custom), and "economic(s)" from "οικ(ο)-" + "νομ(ο)-" + "-ικ(ο)-". The suffix -omics is sometimes used to create names for schools of economics, such as Reaganomics.
== Aviation transportation == Aerial crane operator Air cargo handler Air traffic controller Aircraft marshaller Airline pilot Baggage handler Federal Air Marshal Flight attendant Flight dispatcher Flight engineer Helicopter pilot Loadmaster Pilot Pushback operator
Sources: en.wikipedia.org
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.
It blocks the amino-terminal degradation step that limits native GHRH. The addition extends how long the peptide survives in plasma without removing its ability to activate the receptor.
The chain contains 44 amino acid residues. It matches the human GHRH(1-44) sequence apart from the amino-terminal modification.
Reversed-phase high-performance liquid chromatography with ultraviolet detection is the standard technique for purity and content. Mass spectrometry provides orthogonal confirmation of identity. The two are normally used together rather than in isolation.